South and Central America miRNA Sequencing and Assay Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Library Preparation and Consumables), Technology (Sequencing by Synthesis, Nanopore, and Ion Semiconductor Sequencing), and End User (Research Institute, Academia, and CRO)

Publication Month: May 2021 | Report Code: TIPRE00022199 | No. of Pages: 110 | Category: Biotechnology | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The South and Central America miRNA sequencing and assay market is expected to reach US$ 13.84 million by 2027 from US$ 6.24 million in 2019; it is estimated to grow at a CAGR of 10.6% from 2020 to 2027.

The market growth in this region is mainly attributed to the widening range of microRNA applications and rise in funding for genomics research. However, challenges related to the delivery, efficacy, and specificity of miRNA-based therapeutics hinder the market growth.  

MicroRNAs (miRNAs) are noncoding RNAs that are partially complementary to messenger RNA (mRNA). They are known to downregulate the expression, which makes them vital regulators of important cellular functions. Being involved in the process of differentiation, they act as markers in cell type identification. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs. Furthermore, new discoveries regarding the role of miRNAs in disease development have made them a key target of novel therapeutic approaches. Several miRNA-targeted therapeutics against the diseases such as cancer and hepatitis have reached the clinical phase. For instance, Santaris Pharma has developed a therapeutic molecule named Miravirsen that targets miR-122 for the treatment of hepatitis C virus (HCV) infection; the molecule is in the Phase II clinical trial. Therefore, rise in funding of genomic research to identify new molecules to diagnose and treat diseases, and consequent expansion of the range of applications of miRNAs are driving the growth of the miRNA sequencing and assay market in South and Central America.

Countries in the are witnessing severe effects of the COVID-19 pandemic. Currently, these countries are rapidly boosting various clinical programs to manage this disease. The increasingly high focus on innovative diagnostic techniques that has resulted in growing adoption of sequencing and genomic assay methods. Eurofins genomics has donated 100,000 fast PCR tests to detect SARS-CoV-2 to hospitals in Brazil. In addition, the key players have also shifted their focus toward the development of advanced instruments and products, which could aid in COVID-19 diagnosis. Hence, the COVID-19 is supporting the South and Central America miRNA sequencing and assay market growth.
 South and Central America miRNA sequencing and assay market

Get more information on this report :


South and Central America miRNA Sequencing and Assay Market Segmentation

By Product

  • Library Preparation
  • Consumables

By Technology

  • Sequencing by Synthesis
  • Nanopore
  • Ion Semiconductor Sequencing

By End User

  • Research Institute
  • Academia
  • CRO

By Country

  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

  • Illumina, Inc
  • THERMO FISHER SCIENTIFIC INC.
  • QIAGEN
  • Perkin Elmer, Inc.
  • Takara Bio Inc.
  • New England Biolabs
  • Norgen Biotek Corp
  • TriLink BioTechnologies Inc.
  • Lexogen GmbH
  • Oxford Nanopore Technologies

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        South and Central America miRNA Sequencing and Assay Market – By Product

1.3.2        South and Central America miRNA Sequencing and Assay Market – By Technology

1.3.3        South and Central America miRNA Sequencing and Assay Market – By End User

1.3.4        South and Central America miRNA Sequencing and Assay market – By Country

2.             miRNA Sequencing and Assay Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             South and Central America miRNA Sequencing and Assay – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinions

5.             miRNA Sequencing and Assay Market – Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Widening Range of MicroRNA Applications

5.1.2        Rise in Funding for Genomics Research

5.2       Market Restraints

5.2.1        Challenges Related to Delivery, Efficacy, and Specificity of miRNA-based Therapeutics

5.3       Market Opportunities

5.3.1        Rising Prevalence of Chronic Conditions and Infectious Diseases

5.4       Future Trends

5.4.1        Development and Launch of Innovative Products

5.5       Impact analysis

6.             miRNA Sequencing and Assay Market – South and Central America Analysis

6.1       South and Central America miRNA Sequencing and Assay Market Revenue Forecast and Analysis

7.             miRNA Sequencing and Assay Market Analysis – By Product

7.1       Overview

7.2       miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)

7.3       Library Preparation

7.3.1        Overview

7.3.2        Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

7.4       Consumables

7.4.1        Overview

7.4.2        Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.             miRNA Sequencing and Assay Market Analysis – By Technology

8.1       Overview

8.2       miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027, (%)

8.3       Sequencing by Synthesis

8.3.1        Overview

8.3.2        Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Nanopore

8.4.1        Overview

8.4.2        Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Ion Semiconductor Sequencing

8.5.1        Overview

8.5.2        Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.             miRNA Sequencing and Assay Market Analysis – By End User

9.1       Overview

9.2       miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027, (%)

9.3       Research Institute

9.3.1        Overview

9.3.2        Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.4       Academia

9.4.1        Overview

9.4.2        Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.5       Contract Research Organizations (CROs)

9.5.1        Overview

9.5.2        Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.          miRNA Sequencing and Assay Market –South and Central America Analysis

10.1    South and Central America: miRNA sequencing and assay Market

10.1.1     Overview

10.1.2     South and Central America: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     South and Central America: miRNA sequencing and assay Market, by Product, 2018–2027 (USD Million)

10.1.4     South and Central America: miRNA sequencing and assay Market, by Technology 2018–2027 (USD Million)

10.1.5     South and Central America: miRNA sequencing and assay Market, by End User, 2018–2027 (USD Million)

10.1.6     South and Central America: miRNA sequencing and assay Market, by Country, 2019 & 2027 (%)

10.1.7     Brazil: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    Brazil: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    Brazil: miRNA sequencing and assay Market, by Product, 2018–2027 (USD Million)

10.1.7.3    Brazil: miRNA sequencing and assay Market, by Technology 2018–2027 (USD Million)

10.1.7.4    Brazil: miRNA sequencing and assay Market, by End User, 2018–2027 (USD Million)

10.1.8     Argentina: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    Argentina: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Argentina: miRNA sequencing and assay Market, by Product, 2018–2027 (USD Million)

10.1.8.3    Argentina: miRNA sequencing and assay Market, by Technology 2018–2027 (USD Million)

10.1.8.4    Argentina: miRNA sequencing and assay Market, by End User, 2018–2027 (USD Million)

10.1.9     Rest of South and Central America: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1    Rest of South and Central America: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    Rest of South and Central America: miRNA sequencing and assay Market, by Product, 2018–2027 (USD Million)

10.1.9.3    Rest of South and Central America: miRNA sequencing and assay Market, by Technology 2018–2027 (USD Million)

10.1.9.4    Rest of South and Central America: miRNA sequencing and assay Market, by End User, 2018–2027 (USD Million)

11.          Impact of COVID-19 Pandemic on South and Central America miRNA Sequencing and Assay Market

11.1    South & Central America: Impact Assessment of COVID-19 Pandemic

12.          Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic Developments

12.3.1     Overview

13.         Company Profiles

13.1    Illumina, Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    THERMO FISHER SCIENTIFIC INC.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Perkin Elmer, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Takara Bio Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    New England Biolabs

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Norgen Biotek Corp

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    TriLink BioTechnologies Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Lexogen GmbH

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Oxford Nanopore Technologies

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms


 

LIST OF TABLES

Table 1.             South and Central America miRNA sequencing and assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             South and Central America miRNA sequencing and assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 3.             South and Central America miRNA sequencing and assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             Brazil miRNA sequencing and assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             Brazil miRNA sequencing and assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 6.             Brazil miRNA sequencing and assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             Argentina miRNA sequencing and assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             Argentina miRNA sequencing and assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 9.             Argentina miRNA sequencing and assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.          Rest of South and Central America miRNA sequencing and assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.          Rest of South and Central America miRNA sequencing and assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          Rest of South and Central America miRNA sequencing and assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Inorganic Developments Done by Companies

Table 15.          Glossary of Terms, miRNA Sequencing and Assay Market

LIST OF FIGURES

Figure 1.           miRNA Sequencing and Assay Market Segmentation

Figure 2.           miRNA Sequencing and Assay Market Segmentation, By Country

Figure 3.           South and Central America miRNA Sequencing and Assay Market Overview

Figure 4.           Library Preparation Segment by Product Segment Expected to Witness Rapid Growth

Figure 5.           South and Central America miRNA Sequencing and Assay Market – Leading Country Markets (US$ Million)

Figure 6.           South and Central America (SCAM) PEST Analysis

Figure 7.           miRNA Sequencing and Assay Market Impact Analysis of Driver and Restraints

Figure 8.           South and Central America miRNA Sequencing and Assay Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9.           miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)

Figure 10.        Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027 (%)

Figure 13.        Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027 (%)

Figure 17.        Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        South and Central America: miRNA sequencing and assay Market, by Key Country – Revenue (2019) (USD Million)

Figure 21.        South and Central America miRNA sequencing and assay Market Revenue and Forecast to 2027 (USD Million)

Figure 22.        South and Central America: miRNA sequencing and assay Market, by Country, 2019 & 2027 (%)

Figure 23.        Brazil: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Argentina: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        Rest of South and Central America: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Impact of COVID-19 Pandemic in South & Central America Market

 

  1. Illumina, Inc
  2. THERMO FISHER SCIENTIFIC INC.
  3. QIAGEN
  4. Perkin Elmer, Inc.
  5. Takara Bio Inc.
  6. New England Biolabs
  7. Norgen Biotek Corp
  8. TriLink BioTechnologies Inc.
  9. Lexogen GmbH
  10. Oxford Nanopore Technologies
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America miRNA sequencing and assay market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America miRNA sequencing and assay market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

 

TIPRE00022199
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing